Pulmonary embolism special scenario pregnancy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(→Cancer) |
||
Line 12: | Line 12: | ||
===Cancer=== | ===Cancer=== | ||
* | * The recurrence rate of pulmonary emboli is 30% after a year. | ||
* For treatment [[LMWH]] is recommended for | * For treatment [[LMWH]] is recommended for the first 3 - 6 months.(Grade 1A) | ||
* Later [[warfarin]] can be used after 3-6 months. | * Later, [[warfarin]] can be used after 3-6 months. | ||
* Anticoagulation should be continued | * Anticoagulation should be continued. | ||
==References== | ==References== |
Revision as of 20:12, 10 October 2012
Pulmonary Embolism Microchapters |
Diagnosis |
---|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
Treatment |
Follow-Up |
Special Scenario |
Trials |
Case Studies |
Pulmonary embolism special scenario pregnancy On the Web |
Directions to Hospitals Treating Pulmonary embolism special scenario pregnancy |
Risk calculators and risk factors for Pulmonary embolism special scenario pregnancy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Special Scenario
Pregnancy
- LMWH is the preferred treatment. (Grade 1C)
- Warfarin is contraindicated.
- Embryopathy is at increased risk at 6 - 12 weeks. (Grade 2C)
- Continue anticoagulation for 6 weeks or more postpartum. (Grade 1C)
- Heparin and warfarin are safe for nursing infants.
Cancer
- The recurrence rate of pulmonary emboli is 30% after a year.
- For treatment LMWH is recommended for the first 3 - 6 months.(Grade 1A)
- Later, warfarin can be used after 3-6 months.
- Anticoagulation should be continued.